Dynavax Technologies

Yahoo Finance • 15 days ago

We Did The Math RWJ Can Go To $54

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 22 days ago

CDC vaccines panel votes to change recommendation for MMRV vaccine for children

[Doctor vaccinating a small child. Pediatrician giving an injection.vaccine] Artur Komisarenko/iStock via Getty Images The CDC's Advisory Committee on Immunization Practices, in which five of its 12 members were just added [https://seekin... Full story

Yahoo Finance • 25 days ago

Dynavax Technologies Enters Oversold Territory (DVAX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • last month

CDC vaccine advisory panel sets September meeting dates

[CDC Headquarters Sign - Atlanta GA] csraphotography The CDC's Advisory Committee on Immunization Practices (ACIP), which makes determinations on the segments of the population that should receive vaccinations, will next meet on Sept. 18... Full story

Yahoo Finance • 2 months ago

Goldman Sachs reiterates Sell rating on Dynavax stock despite positive trial data

Investing.com - Goldman Sachs has reiterated its Sell rating and $11.00 price target on Dynavax Technologies (NASDAQ:DVAX), currently trading at $11.12, following the company’s announcement of topline results from its shingles vaccine tria... Full story

Yahoo Finance • 2 months ago

Dynavax's SWOT analysis: heplisav-b success drives stock outlook amid pipeline progress

Dynavax Technologies Corporation (NASDAQ:DVAX) continues to demonstrate strong performance, driven primarily by its flagship product HEPLISAV-B. With impressive revenue growth of 26.66% over the last twelve months and a robust gross margin... Full story

Yahoo Finance • 4 months ago

Dynavax Urges Stockholders To Re-Elect All Four Director Nominees Ahead Of June 11 Meeting

(RTTNews) - Dynavax Technologies (DVAX) has urged stockholders to vote in favor of its four board nominees—Brent MacGregor, Scott Myers, Lauren Silvernail, and Elaine Sun—at the upcoming Annual Meeting on June 11, 2025. The company emphas... Full story

Yahoo Finance • 6 months ago

Deep Track Capital Comments on Dynavax Technologies’ Rejection of Most Recent Settlement Offer

Believes Company’s Unwillingness to Reach Mutually Acceptable Resolution – And Opposition to Giving Shareholders a Voice in the Boardroom – Underscores the Board’s Entrenchment and the Clear Need for Investor-Driven Change GREENWICH, Conn... Full story

Yahoo Finance • last year

Federated Hermes, Inc. Reduces Stake in Dynavax Technologies Corp

Overview of the Recent Transaction On August 31, 2024, Federated Hermes, Inc., a prominent investment firm, executed a significant transaction involving the shares of Dynavax Technologies Corp (NASDAQ:DVAX). The firm reduced its holdings... Full story

Yahoo Finance • last year

Analysts Are Updating Their Dynavax Technologies Corporation (NASDAQ:DVAX) Estimates After Its First-Quarter Results

Dynavax Technologies Corporation (NASDAQ:DVAX) just released its latest first-quarter report and things are not looking great. Revenues missed expectations somewhat, coming in at US$51m, but statutory earnings fell catastrophically short,... Full story

Yahoo Finance • last year

Dynavax Technologies First Quarter 2024 Earnings: Misses Expectations

Dynavax Technologies (NASDAQ:DVAX) First Quarter 2024 Results Key Financial Results Revenue: US$50.8m (up 8.2% from 1Q 2023). Net loss: US$8.72m (loss narrowed by 64% from 1Q 2023). US$0.067 loss per share (improved from US$0.19 loss in... Full story

Yahoo Finance • last year

11 Best Low Price Pharma Stocks To Invest In

In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Be... Full story

Yahoo Finance • 2 years ago

Dynavax to Present at TD Cowen's 44th Annual Health Care Conference

EMERYVILLE, Calif., Feb. 27, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will prese... Full story

Yahoo Finance • 2 years ago

Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript

Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript February 22, 2024 Dynavax Technologies Corporation isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details... Full story

Yahoo Finance • 2 years ago

Insider Sell: President & COO David Novack Sells 20,000 Shares of Dynavax Technologies Corp

On November 1, 2023, David Novack, President & COO of Dynavax Technologies Corp (NASDAQ:DVAX), sold 20,000 shares of the company. This move is part of a larger trend for the insider, who over the past year has sold a total of 189,719 share... Full story

Yahoo Finance • 2 years ago

10 Best Revenue Growth Stocks to Buy

In this piece, we will take a look at the ten best revenue growth stocks to buy. If you want to skip over the latest news for the stock market and want to jump ahead to the top five stocks in this list, then take a look at 5 Best Revenue G... Full story

Yahoo Finance • 2 years ago

Chuck Royce Portfolio, Performance and Net Worth

In this piece, we will take a look at millionaire Chuck Royce's investment portfolio, his net worth and the overall performance of the stocks. If you want to skip our introduction of the investor, his trading strategy, and details about hi... Full story

Yahoo Finance • 3 years ago

Valneva Provides Clinical and Regulatory Updates for its COVID-19 Vaccine VLA2001

Saint-Herblain(France), March 2, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced additional data from remaining clinical studies and an update on regulatory submissions for its inactivate... Full story

Yahoo Finance • 3 years ago

Valneva fournit des informations cliniques et règlementaires concernant son vaccin contre la COVID-19 VLA2001

Saint-Herblain (France), 2 mars 2023 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, annonce aujourd'hui de nouvelles données pour son vaccin contre la COVID-19, VLA2001, provenant d’études cliniq... Full story

Yahoo Finance • 3 years ago

13 High Growth Pharma Stocks that are Profitable

In this piece, we will take a look at 13 high growth pharma stocks that are profitable. For more stocks, head on over to 5 High Growth Pharma Stocks that are Profitable. One industry that has rapidly evolved with time and impacted million... Full story